右美托咪定早期镇静与常规镇静对机械通气危重患者应激反应的影响
这项前瞻性研究嵌套于多中心随机对照试验,比较早期以右美托咪定为主镇静与常规镇静对机械通气危重成人应激反应的影响。主要终点为随机化后5天内血浆应激反应生物标志物的组间平均差异。共103例纳入最终分析,右美托咪定组与常规组的肾上腺素、去甲肾上腺素、促肾上腺皮质激素和皮质醇几何均值均无差异,其他生物标志物和生理参数也无显著差异;敏感性分析显示年龄或脓毒症对结果无影响。结论认为右美托咪定早期主镇静在应激反应相关生理和血液参数变化上与常规镇静相当。
要点
- 在机械通气危重成人中,早期以右美托咪定为主镇静5天内肾上腺素几何均值0.32(95%CI 0.26-0.4) vs 常规镇静0.38(95%CI 0.31-0.48),无差异。
- 去甲肾上腺素几何均值右美托咪定组4.27(95%CI 3.12-5.85) vs 常规组6.2(95%CI 4.6-8.5),无差异。
- 促肾上腺皮质激素几何均值17.1(95%CI 15.1-19.5) vs 18.1(95%CI 15.9-20.5),皮质醇515(95%CI 409-648) vs 618(95%CI 491-776),均无差异。
- 常规组更多患者使用咪达唑仑(57.7% vs 33.3%;p=0.01)且剂量更高(中位数0.46 [0.20-0.93] vs 0.14 [0.08-0.38] mg/kg/day;p<0.01)。
- 敏感性分析显示年龄或脓毒症对结果无影响。
适用人群与场景
- 机械通气危重成人,纳入多中心随机对照试验的预设亚组,最终分析103例。
研究设计与关键结果
- 研究类型为前瞻性研究,嵌套于多中心随机对照试验,比较早期以右美托咪定为主镇静与常规镇静。
- 主要终点为随机化后5天内血浆应激反应生物标志物的组间平均差异。
- 共103例纳入最终分析;基线APACHE II评分、接受丙泊酚的比例及丙泊酚中位剂量组间可比。
- 常规组更多患者使用咪达唑仑(57.7% vs 33.3%;p=0.01)且剂量更高(中位数0.46 [0.20-0.93] vs 0.14 [0.08-0.38] mg/kg/day;p<0.01)。
- 肾上腺素几何均值(95%CI)右美托咪定组0.32(0.26-0.4) vs 常规组0.38(0.31-0.48),无差异。
- 去甲肾上腺素几何均值(95%CI)右美托咪定组4.27(3.12-5.85) vs 常规组6.2(4.6-8.5),无差异。
- 促肾上腺皮质激素几何均值(95%CI)右美托咪定组17.1(15.1-19.5) vs 常规组18.1(15.9-20.5),无差异。
- 皮质醇几何均值(95%CI)右美托咪定组515(409-648) vs 常规组618(491-776),无差异。
证据类型、等级与局限
- 证据类型:前瞻性研究,嵌套于多中心随机对照试验的预设亚组分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于机械通气危重成人,早期以右美托咪定作为主要镇静剂与常规镇静相比,应激反应相关生理和血液参数变化相当,原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Sedative agents may variably impact the stress response. Dexmedetomidine is a sympatholytic alpha2-adrenergic agonist mainly used as a second-line sedative agent in mechanically ventilated patients. We hypothesised that early sedation with dexmedetomidine as the primary agent would result in a reduced stress response compared to usual sedatives in critically ill ventilated adults.
METHODS: This was a prospective sub-study nested within a multi-centre randomised controlled trial of early sedation with dexmedetomidine versus usual care. The primary outcome was the mean group differences in plasma levels of stress response biomarkers measured over 5 days following randomisation. Other hormonal, biological and physiological parameters were collected. Subgroup analyses were planned for patients with proven or suspected sepsis.
RESULTS: One hundred and three patients were included in the final analysis. Baseline illness severity (APACHE II score), the proportion of patients receiving propofol and the median dose of propofol received were comparable between groups. More of the usual-care patients received midazolam (57.7% vs 33.3%; p = 0.01) and at higher dose (median (95% interquartile range) 0.46 [0.20-0.93] vs 0.14 [0.08-0.38] mg/kg/day; p < 0.01). The geometric mean (95% CI) plasma level of the stress hormones, adrenaline (0.32 [0.26-0.4] vs 0.38 [0.31-0.48]), noradrenaline (4.27 [3.12-5.85] vs 6.2 [4.6-8.5]), adrenocorticotropic hormone (17.1 [15.1-19.5] vs 18.1 [15.9-20.5]) and cortisol (515 [409-648] vs 618 [491-776)] did not differ between dexmedetomidine and usual-care groups, respectively. There were no significant differences in any other assayed biomarkers or physiological parameters Sensitivity analyses showed no effect of age or sepsis.
CONCLUSIONS: Early sedation with dexmedetomidine as the primary sedative agent in mechanically ventilated critically ill adults resulted in comparable changes in physiological and blood-borne parameters associated with the stress-response as with usual-care sedation.
参考来源
- Moore JPR, Shehabi Y, Reade MC, et al. Stress response during early sedation with dexmedetomidine compared with usual-care in ventilated critically ill patients. Crit Care. 2022. PMID: 36419197. doi:10.1186/s13054-022-04237-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。